GSK reports positive data from trial of cancer drug Dostarlimab Garima21 March 2019 3:45 AMGSK said it would apply for marketing approval for Dostarlimab in endometrial cancer at the end of 2019.New Delhi: GlaxoSmithKline said on Tuesday a...